Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions

European Journal of Nuclear Medicine

Volumn 25, Issue 5, 1998, Pages 491-496

  Uriarte, Isabel ^a   Carril, Jose Manuel ^a   Quirce, Remedios ^a   Gutiérrez Mendiguchía, Ceferino ^a   Blanco, Isabel ^a   Banzo, Ignacio ^a   Vega, Alfonso ^a   Hernández, Ana ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Breast cancer; Mammography; Scintimammography; Technetium 99m methoxyisobutylisonitrile

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST LESION; CANCER DIAGNOSIS; CLINICAL TRIAL; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREDICTION; SCINTIGRAPHY; X RAY ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0031781014     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050248     Document Type: Article

References (23)

1. Cannon-Albright LA, Skolnick MH. The genetics of familial breast cancer. Semin Oncol 1996; 23 Suppl 2: 1-5.
2. Wingo PA, Tong T, Bolden S. Cancer statistics 1995. C A Cancer J Clin 1995; 45: 8-30.
3. Byrne C, Smart C, Chu K, Hartman W. Survival advantage differences by age. Cancer Suppl 1994; 74: 301-310.
4. Kerlikowske K, Grady D, Rubin S, Sandrock C, Ernster V. Efficacy of screening mammography. JAMA 1995; 273: 149-154.
5. Hamblin A, Mason E, Ramshaw B. Twenty-year review of a breast cancer screening project. Ninety-five percent survival of patients with non-palpable cancers. Cancer 1996; 77: 104-106.
6. Harris Jr, Lippman M, Veronesi U, Willet W. Breast cancer. N Engl J Med 1992; 327: 319-327.
7. Kopans D. Early breast cancer detection using techniques other than mammography. AJR 1884; 143: 465-468.
8. Khalkhali I, Cutrone JA, Diggles L, Mishkin F. The role of nuclear medicine imaging for the evaluation of patients with breast abnormalities. In: Freeman L, ed. Nuclear medicine annual. Philadelphia: Lippincott-Raven; 1996: 113-142.
9. Kerlikowske K, Grady D, Barclay J, Sides E, Ernster V. Likelihood ratios tor modern screening mammmography. Risk of breast cancer based on age and mammography interpretation. JAMA 1996; 276: 39-43.
10. Kopans D. The positive predictive value of mammography. AJR 1992; 158: 521-526.
11. Khalkhali I, Mena I, Jouanne E, Diggles L, Alle K, Klein S. Tc-99m-sestamibi prone breast imaging in patients (pts) with suspicion of breast cancer (ca). J Nucl Med 1993; 34: 140p.
12. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994; 21: 432-436.
13. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Khalkhali S, Moss J, Klein S. Scintimammography: the complementary role of 99m-Tc-sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995; 196: 421-426.
14. Tabuenca O, Quirce R, Gómez-Barquín R, Blanco I, Uriarte I, Vega A, Carril JM. La gammagrafía con MIBI-99m-Tc en el diagnóstics del carcinoma primario de mama en 28 pacientes con criterios mamográficos de malignidad. Rev Esp Med Nucl 1996; 15: 149-153.
15. American College of Radiology. Mammographic data base system (Bird™). Reston, Va.: American College of Radiology, 1993.
16. Sullivan DC. Needle core biopsy of mammographic lesions. AJR 1994; 17: 1677-1682.
17. Waxman AD. The role of 99m-Tc-methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med 1997; 27: 40-54.
18. 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy. Anticancer Res 1997; 17: 1677-1682.
19. Villanueva-Meyer J, Leonard M Jr, Brisroe E, Cesani F, Ali S, Rhoden S, Hove M, Cowan D. Mammoscintigraphy with Technetium-99m-sestamibi in suspected breast cancer. J Nucl Med 1996; 37: 926-930.
20. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Klein S. Technetium-99m sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995; 36: 1784-1789.
21. Palmedo H, Schomburg A, Grünwald F, Mallman P, Krebs D, Biersack H. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996; 37: 626-630.
22. Tiling R, Sommer H, Pechman M, Moser R, Kress K, Pfluger T, Tatsh K, Hahn K. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions. J Nucl Med 1997; 38: 58-62.
23. Burak Z, Argon M, Memis A, Erdem S, Balkan Z, Duman Y, Üstüm E, Erhan Y, Ozkiliç H. Evaluation of palpable breast masses with 99m-Tc-MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994; 15: 604-612.